Giant morphea-form basal cell carcinoma of the umbilicus: Successful debulking with vismodegib

Basal cell carcinoma of the umbilicus is very rare. The nodular subtype is the main representative. Giant basal cell carcinomas represent around 1% of all basal cell carcinomas. The hedgehog pathway inhibitor vismodegib is indicated for advanced basal cell carcinoma and CD56-negative immunostaining...

Descripción completa

Detalles Bibliográficos
Autores principales: Orduz Robledo, Mariana, Lebas, Eve, Reginster, Marie-Annick, Baghaie, Mahmoud, Groves, Sabine, Nikkels, Arjen F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946607/
https://www.ncbi.nlm.nih.gov/pubmed/29760872
http://dx.doi.org/10.1177/2036361318772938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946607/
https://www.ncbi.nlm.nih.gov/pubmed/29760872
http://dx.doi.org/10.1177/2036361318772938

Ejemplares similares